Amicus Therapeutics, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a FOLD research report →
About the company
Amicus Therapeutics, Inc. is a biotechnology firm dedicated to the discovery, development, and delivery of medical treatments for rare conditions. Its primary commercial offering is Galafold, an orally administered precision medicine designed for adult patients with a confirmed diagnosis of Fabry disease, specifically those exhibiting an amenable galactosidase alpha gene variant as identified by in vitro assay data.
- CEO
- Bradley L. Campbell
- IPO
- 2007
- Employees
- 499
- HQ
- Philadelphia, PA, US
Price Chart
- Market Cap
- $4.55B
- P/E
- -163.73
- P/S
- 7.17
- P/B
- 16.33
- EV/EBITDA
- 89.56
- Div Yield
- 0.00%
- Gross Margin
- 87.91%
- Op Margin
- 5.17%
- Net Margin
- -4.27%
- ROE
- -12.02%
- ROIC
- -645.68%
- Revenue
- $634.21M · 20.05%
- Net Income
- $-27,110,000 · 51.68%
- EPS
- $-0.09 · 51.17%
- Op Income
- $34.49M
- FCF YoY
- 179.72%
- 52W High
- $14.50
- 52W Low
- $5.51
- 50D MA
- $14.40
- 200D MA
- $10.88
- Beta
- 0.48
- Avg Volume
- 4.15M
Get TickerSpark's AI analysis on FOLD
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Apr 27, 26 | WHEELER CRAIG A | sell | 84,631 |
| Apr 27, 26 | WHEELER CRAIG A | sell | 30,000 |
| Apr 27, 26 | WHEELER CRAIG A | sell | 16,236 |
| Apr 27, 26 | WHEELER CRAIG A | sell | 19,473 |
| Apr 27, 26 | WHEELER CRAIG A | sell | 18,574 |
| Apr 27, 26 | WHEELER CRAIG A | sell | 36,111 |
| Apr 27, 26 | WHEELER CRAIG A | sell | 45,423 |
| Apr 27, 26 | WHEELER CRAIG A | sell | 30,474 |
| Apr 27, 26 | WHEELER CRAIG A | sell | 42,467 |
| Apr 27, 26 | WHEELER CRAIG A | sell | 74,872 |
Our FOLD coverage
Recent articles, reports, and earnings notes.
Want a deeper read on FOLD?
Generate a full analyst-grade report — bull/bear case, price targets, valuation depth, and a complete financial breakdown.
Similar companies
Peers in the same neighborhood.